A phase II trial of dasatinib in patients with unresectable locally advanced or stage IV mucosal, acral, and solar melanomas: An Eastern Cooperative Oncology Group study (E2607).
Kevin Kalinsky
No relevant relationships to disclose
Sandra J. Lee
No relevant relationships to disclose
Donald P. Lawrence
No relevant relationships to disclose
A. John Iafrate
No relevant relationships to disclose
Darrell R. Borger
Consultant or Advisory Role - Bio-Reference Laboratories; Licensee of SNaPshot genotyping platform
Bruce Jeffrey Averbook
No relevant relationships to disclose
Ahmad A. Tarhini
Consultant or Advisory Role - Genentech; MedImmune; Prometheus
Research Funding - Amgen; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Prometheus
John M. Kirkwood
No relevant relationships to disclose